New York State Common Retirement Fund Nurix Therapeutics, Inc. Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 21,195 shares of NRIX stock, worth $367,733. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21,195
Previous 21,195
-0.0%
Holding current value
$367,733
Previous $476,000
16.18%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NRIX
# of Institutions
185Shares Held
70.6MCall Options Held
318KPut Options Held
42.4K-
Black Rock Inc. New York, NY6.82MShares$118 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.35MShares$75.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.19MShares$72.7 Million6.18% of portfolio
-
Baker Bros. Advisors LP New York, NY3.88MShares$67.4 Million0.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.59MShares$62.2 Million0.01% of portfolio
About Nurix Therapeutics, Inc.
- Ticker NRIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,147,800
- Market Cap $818M
- Description
- Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...